Clinical Trials
Numerous clinical trials spanning early Phase 1 through Phase 4 evaluate therapies for conditions such as healthy adult pharmacokinetics, advanced melanoma, Crohn's disease, oral ulcers, enamel erosion, dengue, and pediatric solid tumors. Sponsored by government organizations—including the National Cancer Institute and U.S. Army Medical Research and Development Command—and commercial entities like GlaxoSmithKline and Teva Pharmaceuticals USA, these studies encompass active, completed, terminated, and withdrawn recruitment statuses. Notably, completed research includes Phase 1 pharmacokinetic studies in healthy volunteers and pediatric solid tumor evaluations.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT04877288 | RECRUITING | Renal Allograft Recipients |
Bristol-Myers Squibb |
2021-07-21 | PHASE3 |
| NCT07055087 | NOT_YET_RECRUITING | Parkinson's Disease |
University Hospital Tuebingen |
2025-12 | PHASE2 |
| NCT06364930 | RECRUITING | Chronic Hepatitis B |
Chinese University of Hong Kong |
2024-03-26 | PHASE4 |
| NCT06625073 | RECRUITING | Heart Transplant; Cardiovascular Disease; Kidney Disease |
VA Office of Research and Development |
2026-01-20 | PHASE4 |
| NCT06190158 | ACTIVE_NOT_RECRUITING | Type 2 Diabetes; Chronic Kidney Diseases |
Brigham and Women's Hospital |
2024-05-15 | EARLY_PHASE1 |
| NCT06870448 | NOT_YET_RECRUITING | Acute Ischemic Stroke |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2025-04 | PHASE3 |
| NCT07175649 | NOT_YET_RECRUITING | Ischemic Stroke, Acute |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2025-10 | |
| NCT07070765 | RECRUITING | Breast Cancer |
University of Aberdeen |
2025-12-12 | |
| NCT04546399 | RECRUITING | Down Syndrome; Recurrent B Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2020-12-17 | PHASE2 |
| NCT06247787 | RECRUITING | Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Myelodysplastic Syndrome; Recurrent Juvenile Myelomonocytic Leukemia; Refractory Childhood Acute Myeloid Leukemia; Refractory Childhood Myelodysplastic Syndrome; Refractory Juvenile Myelomonocytic Leukemia |
Children's Oncology Group |
2025-02-04 | PHASE1 |
| NCT07585565 | NOT_YET_RECRUITING | Parkinson's Disease |
Qilu Pharmaceutical Co., Ltd. |
2026-05 | PHASE2 |
| NCT07702799 | RECRUITING | Endometrial Cancer |
Mahmut Yassa |
2026-07-15 | |
| NCT07141303 | RECRUITING | Acute Ischemic Stroke |
Tang-Du Hospital |
2025-08-08 | PHASE3 |
| NCT05761171 | ACTIVE_NOT_RECRUITING | Recurrent Acute Leukemia of Ambiguous Lineage; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage; Recurrent Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged; Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia; Recurrent Mixed Phenotype Acute Leukemia; Refractory Acute Leukemia of Ambiguous Lineage; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage; Refractory Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged; Refractory Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia; Refractory Mixed Phenotype Acute Leukemia |
Children's Oncology Group |
2024-01-08 | PHASE2 |
| NCT07516522 | RECRUITING | Ischemia Stroke; Thrombectomy; Large Vessel Occlusion |
Tang-Du Hospital |
2026-03-31 | PHASE2 |
| NCT06572085 | RECRUITING | Butylphthalide; Cardiac Arrest; Neuroprotective Drugs |
Tang Ziren |
2022-01-01 | PHASE4 |
| NCT07560592 | RECRUITING | Heart Failure |
Maya Guglin, MD |
2026-01-21 | |
| NCT06872060 | NOT_YET_RECRUITING | Kidney Diseases |
Bispebjerg Hospital |
2026-06-01 | |
| NCT07180277 | NOT_YET_RECRUITING | Traumatic Brain Injury |
Zhangjiagang First People's Hospital |
2025-10-01 | PHASE4 |
| NCT07796048 | NOT_YET_RECRUITING | Primary Aldosteronism; Hypertension |
University of Calgary |
2026-09-30 | |
| NCT07700277 | NOT_YET_RECRUITING | Lower Gastrointestinal Disorder; Tolerance |
Ottawa Hospital Research Institute |
2026-08-01 | EARLY_PHASE1 |
| NCT07761962 | ACTIVE_NOT_RECRUITING | Irreversible Pulpitis (Toothache) |
King Abdullah University Hospital |
2025-10-23 | |
| NCT06351150 | RECRUITING | Vasodilatory Shock |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2024-07-23 | PHASE3 |
| NCT06560333 | WITHDRAWN | Diabetes Mellitus, Type 2 |
Eurofarma Laboratorios S.A. |
2026-11-30 | PHASE3 |
| NCT07709195 | RECRUITING | Oral Mucositis; Total Body Irradiation; Hematological Malignancies; Hematopoietic Stem Cell Transplantation (HSCT) |
Tata Memorial Centre |
2024-10-30 | PHASE2 |
| NCT07547228 | RECRUITING | Neovascular Age Related Macular Degeneration |
Intra-IMMUSG Pte Ltd |
2025-10-11 | PHASE1; PHASE2 |
| NCT05139849 | RECRUITING | Cardiac Arrest;In-hospital Cardiac Arrest; Methylprednisolone; Vasopressin; Adrenaline; Randomized Clinical Trial |
Tiohundra AB |
2021-11-17 | PHASE3 |
| NCT07054801 | RECRUITING | Headaches Associated With Subarachnoid Hemorrhage (SAH) |
Daniel Raper, MBBS |
2026-06-23 | PHASE2 |
| NCT01631617 | RECRUITING | Eczema; Dermatitis; Skin Diseases, Genetic; Dermatitis, Atopic; Skin Diseases |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
2012-09-18 | PHASE2 |
| NCT07747753 | NOT_YET_RECRUITING | Necrotic Pulp |
Ahmed Hesham Abdelmohaimen Rezk |
2026-08 | |
| NCT05129748 | RECRUITING | Ototoxic Hearing Loss |
Sunnybrook Health Sciences Centre |
2023-02-15 | PHASE2 |
| NCT03684278 | RECRUITING | Acute Pancreatitis |
University of Liverpool |
2019-05-01 | PHASE2 |
| NCT07675330 | NOT_YET_RECRUITING | Pulp Disease, Dental; Pulp Therapy in Primary Molars; Pulpitis - Reversible; Pulp Inflammation; Vital Pulp Therapies; Carious Exposure of Pulp; Primary Molar Tooth; Primary Molar Pulpotomy |
Cairo University |
2026-08 | |
| NCT06448143 | NOT_YET_RECRUITING | Ureter Injury |
Prove pharm |
2026-01 | PHASE3 |
| NCT06924983 | NOT_YET_RECRUITING | Stroke; Intracerebral Hemorrhage Basal Ganglia; Methylprednisolone; Surgery |
Yong Jiang |
2025-05-01 | PHASE4 |
| NCT06921616 | NOT_YET_RECRUITING | Stroke; Intracerebral Hemorrhage Lobar; Methylprednisolone; Surgery |
Yong Jiang |
2025-05-01 | PHASE4 |
| NCT07300540 | ACTIVE_NOT_RECRUITING | Dentin Sensitivity |
HALEON |
2026-03-04 | |
| NCT07185633 | NOT_YET_RECRUITING | aGVHD |
Bin Gu |
2025-10-01 | PHASE2 |
| NCT07025525 | NOT_YET_RECRUITING | Pulpectomy Agents |
Cairo University |
2025-08 | |
| NCT07614490 | RECRUITING | Gingivitis; Plaque |
Colgate Palmolive |
2026-04-20 | PHASE4 |
| NCT03401398 | RECRUITING | Septic Shock |
Jerry Zimmerman |
2019-03-11 | PHASE3 |
| NCT07202143 | RECRUITING | Large Infarct Core; Post-stroke Lymphocytopenia |
YiLin |
2025-09-01 | PHASE3 |
| NCT07572994 | NOT_YET_RECRUITING | Myofacial Pain; Myofacial Pain Syndrome; Myofacial Pain Syndromes; Trigger Point Pain, Myofascial; Myofascial Pain Dysfunction Syndrome |
Cairo University |
2026-05-01 | |
| NCT07342868 | COMPLETED | Chronic Hepatitis B Infections |
Aligos Therapeutics |
2026-01-30 | PHASE1 |
| NCT04101188 | RECRUITING | Cardiovascular Risk Factor |
University of Delaware |
2020-01-16 | |
| NCT07606638 | ENROLLING_BY_INVITATION | Oral Cancer; Oral Cavity Cancer; Oral Squamous Cell Carcinoma (OSCC) |
Mayo Hospital Lahore |
2026-02-01 | |
| NCT07214818 | RECRUITING | Nephrotic Syndrome |
Mansoura University |
2025-11-15 | PHASE2; PHASE3 |
| NCT06538584 | RECRUITING | Enhanced Recovery After Surgery in a Pediatric Population |
University of Chicago |
2024-09-09 | PHASE1; PHASE2 |
| NCT06514573 | RECRUITING | Autism Spectrum Disorder (ASD) |
Istituto Superiore di Sanità |
2025-05 | |
| NCT07318103 | RECRUITING | Fluid Retention Caused by Heart Failure |
Fujian Shengdi Pharmaceutical Co., Ltd. |
2025-12-31 | PHASE2 |
| NCT07749027 | COMPLETED | Cataract |
Muhammad Aamir Latif |
2026-01-01 | |
| NCT07596004 | ACTIVE_NOT_RECRUITING | HEMODYNAMIC RESPONSETO LYRANGOSCOPY AND ENDOTRACHEAL INTUBATION |
Shaheed Mohtarma Benazir Bhutto Institue of Trauma |
2026-03-10 | |
| NCT04662723 | RECRUITING | Glomerulonephritis; Immunoglobulin A Nephropathy |
Fondazione Schena |
2023-05-01 | PHASE4 |
| NCT06100939 | COMPLETED | Keratoconus |
Epion Therapeutics |
2023-10-30 | PHASE3 |
| NCT07353307 | COMPLETED | Pain After Abdominal Surgery |
The Third Xiangya Hospital of Central South University |
2025-12-30 | PHASE3 |
| NCT07328880 | RECRUITING | Colonoscopy Preparation |
Tanta University |
2025-04-01 | |
| NCT07628166 | COMPLETED | Impacted Mandibular Third Molar Extraction; Postoperative Pain Control; Postoperative Edema and Pain |
Irfan Üstündağ |
2026-03-02 | |
| NCT07676396 | COMPLETED | Symptomatic Irreversible Pulpitis (SIP) |
October 6 University |
2025-04-01 | PHASE4 |
| NCT06198764 | UNKNOWN | Mental Health Issue |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2023-07-06 | PHASE3 |
| NCT07040709 | COMPLETED | Postoperative Pain Following Knee Arthroplasty |
Tokat Gaziosmanpasa University |
2025-06-08 | |
| NCT06054880 | RECRUITING | Ureter Injury |
Prove pharm |
2023-10-12 | PHASE4 |
| NCT06760455 | RECRUITING | Healthy Participants |
Chengdu Brilliant Pharmaceutical Co., Ltd. |
2025-01-10 | PHASE1 |
| NCT06667622 | UNKNOWN | Chemoradiotherapy |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2024-05-29 | PHASE2 |
| NCT07257588 | ENROLLING_BY_INVITATION | Ulcerative Colitis |
Xijing Hospital of Digestive Diseases |
2024-09-30 | |
| NCT03301558 | WITHDRAWN | Kidney Transplant; Complications |
Prim. Priv. Doz. Dr. Daniel Cejka |
2025-12-31 | PHASE2 |
| NCT06700603 | NOT_YET_RECRUITING | Pancreatic Cancer |
Rui-hua Xu, MD, PhD |
2024-11-20 | PHASE2 |
| NCT07248189 | COMPLETED | Symptomatic Irreversible Pulpitis (SIP) |
Cairo University |
2025-10-01 | |
| NCT03977207 | RECRUITING | Thyroid; Functional Disturbance; Hypothyroidism; Hemodialysis |
University of California, Irvine |
2020-07-20 | |
| NCT06569056 | RECRUITING | Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP) |
Jiangsu HengRui Medicine Co., Ltd. |
2024-09-25 | PHASE3 |
| NCT05396001 | COMPLETED | Hypertension; Blood Pressure |
University of Michigan |
2022-08-15 | |
| NCT06360458 | ACTIVE_NOT_RECRUITING | Acute Ischemic Stroke; Large Infarct Core |
Wan-Jin Chen |
2024-08-01 | PHASE3 |
| NCT06111768 | COMPLETED | Cardiorenal Syndrome |
Yale University |
2024-05-30 | PHASE2 |
| NCT06971055 | NOT_YET_RECRUITING | Dental Caries; Pulp Necrosis; Primary Tooth Pulpectomy; Pediatric Dentistry; Endodontic Infection |
Cairo University |
2025-07-20 | |
| NCT07379762 | COMPLETED | Cesarean Section Pain; Diclofenac; Suppository; Postoperative Pain |
CMH Multan Institute of Medical Sciences |
2025-02-01 | PHASE4 |
| NCT06233565 | COMPLETED | Foot Injuries and Disorders; Ankle Injuries and Disorders |
Poznan University of Medical Sciences |
2024-02-09 | PHASE4 |
| NCT06191328 | UNKNOWN | Diabetes |
Yufan Wang |
2024-01-31 | |
| NCT03783182 | UNKNOWN | Tonsillectomy; Pain; PONV; Bleeding |
Umeå University |
2019-09-10 | PHASE4 |
| NCT06418074 | COMPLETED | Ketosis; Essential Hypertension |
Gødstrup Hospital |
2024-09-11 | |
| NCT06387823 | UNKNOWN | Acute Respiratory Distress Syndrome |
Peking Union Medical College Hospital |
2024-04-15 | |
| NCT06462781 | COMPLETED | Refractory Migraine |
The Cooper Health System |
2024-03-15 | PHASE1 |
| NCT06737653 | ACTIVE_NOT_RECRUITING | Wound Healing; Palate; Wound; Hyaluronic Acid |
University of Roma La Sapienza |
2024-12-22 | |
| NCT06192927 | COMPLETED | Tennis Elbow |
Causeway Therapeutics |
2024-04-10 | PHASE2 |
| NCT05668962 | RECRUITING | Thyroid Cancer; Thyroid Carcinoma; Metastatic Thyroid Cancer; Follicular Thyroid Cancer; Unresectable Thyroid Gland Carcinoma; Papillary Thyroid Cancer |
Massachusetts General Hospital |
2023-03-01 | PHASE2 |
| NCT06304298 | COMPLETED | Knee Arthropathy; Knee Osteoarthritis; Knee Pain Chronic |
Poznan University of Medical Sciences |
2024-03-30 | PHASE4 |
| NCT06087601 | COMPLETED | Osteo Arthritis Knee; Osteoarthritis |
Poznan University of Medical Sciences |
2023-10-17 | PHASE4 |
| NCT07120321 | COMPLETED | Dental Caries; Pulpitis |
Sacide Duman |
2022-01-01 | |
| NCT05877911 | UNKNOWN | Epithelial Ovarian Cancer; Acute Kidney Injury Due to Circulatory Failure |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2023-05 | PHASE2 |
| NCT02342444 | UNKNOWN | Trauma; Surgery; Deep Vein Thrombosis (DVT); Thromboembolic Events |
Oregon Health and Science University |
2014-02 | PHASE4 |
| NCT05263167 | UNKNOWN | Edema Brain |
Beijing Tiantan Hospital |
2022-03-15 | PHASE4 |
| NCT05906303 | UNKNOWN | Second Stage of Labor |
The Reading Hospital and Medical Center |
2023-12-01 | PHASE1 |
| NCT06122987 | UNKNOWN | Septic Shock; Shock; Sepsis; Systemic Inflammatory Response Syndrome |
Kingman Regional Medical Center |
2023-12-04 | PHASE4 |
| NCT06656403 | NOT_YET_RECRUITING | Dry Eye Disease; Tear Film |
He Eye Hospital |
2024-10-30 | |
| NCT05423249 | COMPLETED | Non-anemic Iron Deficiency |
Stony Brook University |
2022-08-12 | |
| NCT03810404 | UNKNOWN | Supplementation; Sport |
Poznan University of Physical Education |
2018-12-20 | PHASE3 |
| NCT06108453 | UNKNOWN | Drug Interactions |
Seoul National University Bundang Hospital |
2023-08-21 | PHASE1 |
| NCT06828874 | COMPLETED | Intraabdominal Infections |
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd |
2023-05-10 | PHASE4 |
| NCT05289050 | UNKNOWN | Postoperative Pain, Acute; Anaesthetic |
Ling Dong |
2022-04-19 | PHASE4 |
| NCT05988788 | COMPLETED | Necrotic Pulp |
Cairo University |
2023-10-01 | |
| NCT06189456 | UNKNOWN | Dry Eye Syndrome (DES) |
Fidia Farmaceutici s.p.a. |
2023-06-21 | |
| NCT05773963 | TERMINATED | Opthalomology/Dry Eye |
Montefarmaco OTC SpA |
2022-02-24 | |
| NCT05871177 | COMPLETED | Peyronie Disease |
IBSA Farmaceutici Italia Srl |
2023-05-21 | |
| NCT00001337 | COMPLETED | Diffuse Large B-Cell Lymphoma (DLBCL); Primary Mediastinal Large B-cell Lymphoma; Burkitt Lymphoma; Anaplastic Large-Cell Lymphoma; Gray Zone Lymphoma |
National Cancer Institute (NCI) |
1993-05-08 | PHASE2 |
| NCT06143670 | COMPLETED | Gingivitis |
HALEON |
2023-11-29 | |
| NCT05869565 | UNKNOWN | Stroke, Acute |
Aga Khan University |
2023-02-01 | PHASE2; PHASE3 |
| NCT03593252 | UNKNOWN | Colostomy; Hirschsprung Disease - Pull Through; Necrotizing Enterocolitis; Inflammatory Bowel Diseases; Meconium Ileus; Bowel Obstruction; Elective Surgery |
McMaster University |
2022-01-01 | |
| NCT05485805 | COMPLETED | Postoperative Dental Pain |
Bayer |
2022-09-21 | PHASE3 |
| NCT05857163 | COMPLETED | H.Pylori Infection |
TenNor Therapeutics (Suzhou) Limited |
2023-05-18 | PHASE3 |
| NCT01347294 | UNKNOWN | Venous Malformation |
Oslo University Hospital |
2011-08 | PHASE4 |
| NCT04756427 | TERMINATED | CLABSI - Central Line Associated Bloodstream Infection |
Johns Hopkins University |
2022-03-28 | PHASE4 |
| NCT03095313 | COMPLETED | Aortic Stenosis |
Cedars-Sinai Medical Center |
2017-07-23 | PHASE2 |
| NCT05320380 | WITHDRAWN | Recurrent Acute Myeloid Leukemia; Recurrent B Acute Lymphoblastic Leukemia; Recurrent Mixed Phenotype Acute Leukemia; Recurrent T Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia; Refractory B Acute Lymphoblastic Leukemia; Refractory Mixed Phenotype Acute Leukemia; Refractory T Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2023-08-01 | PHASE1; PHASE2 |
| NCT05329155 | COMPLETED | STEMI; Primary PCI |
Renmin Hospital of Wuhan University |
2022-07-20 | |
| NCT05772039 | UNKNOWN | Early Childhood Caries; Dental Caries in Children; Dental Caries Extending Into Dentin; Dental Caries; Behavior, Child; Quality of Life |
Universiti Sains Malaysia |
2022-01-18 | PHASE4 |
| NCT05768373 | COMPLETED | Dentin Hypersensitivity |
Solventum US LLC |
2023-04-04 | |
| NCT06278792 | COMPLETED | Acute Decompensated Heart Failure |
Ziekenhuis Oost-Limburg |
2022-03-07 | |
| NCT06683430 | COMPLETED | Hypertension; Older Adults Institutionalized in Residential Homes |
Universitas Airlangga |
2022-05-11 | |
| NCT05305183 | UNKNOWN | Osteoporosis |
Shandong New Time Pharmaceutical Co., LTD |
2022-05-31 | PHASE3 |
| NCT05060744 | UNKNOWN | Oesophageal Reflux; Gastric Reflux; Hyperactivity; Stomach |
Uriach Consumer Healthcare |
2021-09-09 | |
| NCT03745664 | UNKNOWN | Community-acquired Pneumonia |
University of Roma La Sapienza |
2021-01-10 | PHASE3 |
| NCT05519592 | UNKNOWN | Neurologic Disorder; Spastic Hemiplegia; Gait, Hemiplegic; Block |
Henri Mondor University Hospital |
2022-09-09 | |
| NCT05233163 | COMPLETED | Transthyretin Amyloid Cardiomyopathy |
Columbia University |
2022-03-14 | PHASE4 |
| NCT06461975 | COMPLETED | Retinopathy of Prematurity |
Alexandria University |
2023-01-01 | PHASE3 |
| NCT05698758 | UNKNOWN | Cataract; Preoperative Sedation |
Guangzhou First People's Hospital |
2023-01-10 | |
| NCT05188339 | UNKNOWN | Central Venous Catheter Thrombosis; Renal Dialysis |
Chang Gung Memorial Hospital |
2022-07-20 | PHASE2; PHASE3 |
| NCT02883049 | COMPLETED | B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, BCR-ABL1-Like; Central Nervous System Leukemia; Testicular Leukemia |
National Cancer Institute (NCI) |
2012-02-29 | PHASE3 |
| NCT05566197 | UNKNOWN | Metabolic Syndrome; Diabetes; Hyperlipidemias |
Hasanuddin University |
2022-07-15 | |
| NCT04826588 | COMPLETED | Paediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS) |
University Children's Hospital Basel |
2021-05-23 | PHASE3 |
| NCT04112862 | COMPLETED | GLUT1 Deficiency Syndrome; GLUT1DS1; GLUT1DS2; Epilepsy; Lactic Acid Blood Increased; Ketogenic Dieting |
Radboud University Medical Center |
2022-05-20 | EARLY_PHASE1 |
| NCT04860011 | UNKNOWN | Heart Failure |
NHS Greater Glasgow and Clyde |
2021-04-27 | PHASE3 |
| NCT04755712 | COMPLETED | Analgesia |
GCS Ramsay Santé pour l'Enseignement et la Recherche |
2021-03-22 | PHASE4 |
| NCT04659941 | UNKNOWN | COVID 19 Vaccine |
Universidade Federal do Rio de Janeiro |
2020-10-01 | PHASE2 |
| NCT04788550 | UNKNOWN | Orthodontic Appliance Complication |
University of Malaya |
2021-03-17 | |
| NCT03471507 | COMPLETED | Chronic Pain; Musculoskeletal Pain |
Winston Parris, MD |
2020-12-15 | PHASE2 |
| NCT05742126 | COMPLETED | Healthy |
Haisco Pharmaceutical Group Co., Ltd. |
2022-04-11 | PHASE1 |
| NCT04683627 | COMPLETED | Osteoarthritis Pain of the Knee |
Noven Pharmaceuticals, Inc. |
2020-12-29 | PHASE3 |
| NCT04964622 | COMPLETED | Irreversible Pulpitis |
Cairo University |
2021-12-01 | PHASE1; PHASE2 |
| NCT07027670 | COMPLETED | Cardiac Surgical Procedures; Coronary Artery Bypass; Aortic Valve Disease; Mitral Valve Disease |
University of Oxford |
2021-02-01 | PHASE2 |
| NCT02798523 | COMPLETED | Normal Physiology |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-01-24 | PHASE1 |
| NCT05147051 | COMPLETED | Metabolic Acidosis |
POLYSAN Scientific & Technological Pharmaceutical Company |
2021-06-16 | PHASE2 |
| NCT05260359 | COMPLETED | Sunburn |
dsm-firmenich Switzerland AG |
2022-02-23 | PHASE2 |
| NCT04772209 | COMPLETED | Catheter Blockage; Catheter-Related Infections; Dialysis Catheter; Thrombosis; Catheter Infection; Catheter Related Complication; Catheter Dysfunction |
Zonguldak Ataturk State Hospital |
2021-02-01 | |
| NCT04063033 | COMPLETED | Heart Failure |
Rambam Health Care Campus |
2019-09-01 | PHASE4 |
| NCT03606980 | TERMINATED | Apophysitis; Juvenile |
Children's Health System, Inc. |
2018-11-05 | PHASE2 |
| NCT04948164 | UNKNOWN | Migraine in Adults |
Peking University Third Hospital |
2018-08-01 | PHASE3 |
| NCT04445285 | RECRUITING | Covid19 |
Jon Simmons |
2020-04-28 | PHASE2 |
| NCT04847141 | TERMINATED | COVID-19; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection |
Grifols Therapeutics LLC |
2021-04-28 | PHASE3 |
| NCT03558022 | COMPLETED | Hypertension |
Virginia Commonwealth University |
2018-05-15 | |
| NCT04593706 | UNKNOWN | Keloid; Hypertrophic Scar; Scars; Scarring |
Tel-Aviv Sourasky Medical Center |
2020-11-01 | |
| NCT04702802 | COMPLETED | Age-related Cataract; Phacoemulsification |
Laboratorios Sophia S.A de C.V. |
2021-09-07 | |
| NCT03679611 | COMPLETED | Obstructive Sleep Apnea |
University Health Network, Toronto |
2019-01-14 | PHASE4 |
| NCT04130100 | UNKNOWN | Knee Osteoarthritis |
CAR-T (Shanghai) Biotechnology Co., Ltd. |
2019-04-04 | EARLY_PHASE1 |
| NCT03750240 | TERMINATED | Breast Cancer; Triple Negative Breast Cancer |
NYU Langone Health |
2017-07-25 | |
| NCT04247659 | UNKNOWN | Cerebral Infarction; Cerebral Edema |
The Second Hospital of Hebei Medical University |
2020-01-09 | PHASE4 |
| NCT04421300 | COMPLETED | Dry Eye; Keratoconjunctivitis Sicca; Eye Diseases; Corneal Diseases; Conjunctival Diseases |
Zhongshan Ophthalmic Center, Sun Yat-sen University |
2020-07-02 | |
| NCT06022588 | COMPLETED | Chronic Mesenteric Ischemia |
Erasmus Medical Center |
2021-03-01 | |
| NCT04007328 | UNKNOWN | Pneumonia, Bacterial |
Taipei Medical University WanFang Hospital |
2019-06-15 | PHASE2; PHASE3 |
| NCT03193346 | WITHDRAWN | Migraine Disorders |
Allergan |
2017-07-03 | PHASE3 |
| NCT03012815 | COMPLETED | Alcohol Withdrawal Syndrome |
Mayo Clinic |
2017-02-01 | PHASE4 |
| NCT04301479 | UNKNOWN | Vasoplegia; Cardiac Surgery |
Instituto do Coracao |
2020-03 | PHASE3 |
| NCT04035330 | UNKNOWN | Necrotic Pulp |
Cairo University |
2019-09 | |
| NCT04219995 | UNKNOWN | Intractable Epilepsy; Convulsive Seizures |
Louisiana State University Health Sciences Center in New Orleans |
2020-02-03 | PHASE1; PHASE2 |
| NCT04569045 | COMPLETED | Dermal Filler; Hyaluronic Acid; Lidocaine; Nasolabial Fold |
SciVision Biotech Inc. |
2020-08-20 | |
| NCT04530578 | UNKNOWN | Covid19; Pneumonia |
Clinica San Camilo, Argentina |
2020-06-01 | PHASE4 |
| NCT02828358 | COMPLETED | Acute Leukemia of Ambiguous Lineage; B Acute Lymphoblastic Leukemia; Mixed Phenotype Acute Leukemia |
National Cancer Institute (NCI) |
2017-04-01 | PHASE2 |
| NCT04377503 | TERMINATED | Cytokine Release Syndrome; Covid-19 |
Hospital Sao Domingos |
2020-05-01 | PHASE2 |
| NCT04380090 | COMPLETED | Constipation |
The Cleveland Clinic |
2020-02-21 | PHASE2 |
| NCT03523715 | TERMINATED | Constipation |
University of Southern California |
2017-11-30 | PHASE4 |
| NCT04343729 | COMPLETED | SARS-CoV Infection; Severe Acute Respiratory Syndrome (SARS) Pneumonia |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
2020-04-18 | PHASE2 |
| NCT03965182 | UNKNOWN | Bowel Preparation |
Dalin Tzu Chi General Hospital |
2019-06-01 | |
| NCT04266288 | COMPLETED | Depression; Depression Severe; Depression Acute; Depression and Suicide; Suicidal Ideation |
MercyOne Des Moines Medical Center |
2019-10-18 | PHASE4 |
| NCT02057718 | COMPLETED | Progressive Familial Intrahepatic Cholestasis (PFIC) |
Mirum Pharmaceuticals, Inc. |
2014-03-01 | PHASE2 |
| NCT03423797 | COMPLETED | Early Childhood Caries |
The University of Hong Kong |
2017-09-01 | PHASE3 |
| NCT02112916 | ACTIVE_NOT_RECRUITING | Adult T Acute Lymphoblastic Leukemia; Ann Arbor Stage II Adult Lymphoblastic Lymphoma; Ann Arbor Stage II Childhood Lymphoblastic Lymphoma; Ann Arbor Stage III Adult Lymphoblastic Lymphoma; Ann Arbor Stage III Childhood Lymphoblastic Lymphoma; Ann Arbor Stage IV Adult Lymphoblastic Lymphoma; Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma; Childhood T Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2014-10-04 | PHASE3 |
| NCT03128177 | COMPLETED | Hypertension; Obstructive Sleep Apnea |
University of Alabama at Birmingham |
2016-01-01 | |
| NCT03428464 | COMPLETED | Kidney Transplant; Complications; Metabolic Acidosis |
University of Colorado, Denver |
2018-12-05 | |
| NCT03851705 | COMPLETED | Homozygous Familial Hypercholesterolemia |
Novartis Pharmaceuticals |
2019-02-06 | PHASE3 |
| NCT03424317 | TERMINATED | Sodium Intake; Resistant Hypertension |
DongGuk University |
2018-01-01 | |
| NCT04215042 | UNKNOWN | Acute Kidney Injury |
Ospedale Misericordia e Dolce |
2016-05-01 | |
| NCT03165344 | COMPLETED | Esophageal Stenosis Acquired |
Peking University Third Hospital |
2017-02-10 | |
| NCT03990935 | UNKNOWN | White Spot Lesions |
Cairo University |
2019-07 | |
| NCT01573572 | COMPLETED | Age-Related Macular Degeneration; Retinal Vein Occlusion; Diabetic Macular Edema |
Bausch & Lomb Incorporated |
2010-04-22 | PHASE4 |
| NCT02433977 | COMPLETED | Asthma |
Gladwin, Mark, MD |
2015-09 | PHASE2 |
| NCT02977286 | TERMINATED | Constipation |
Tufts Medical Center |
2017-01-01 | PHASE4 |
| NCT04075175 | COMPLETED | Diphtheria |
MassBiologics |
2019-04-23 | PHASE1 |
| NCT03570554 | COMPLETED | Osteoarthritis, Knee |
Bayer |
2018-06-29 | PHASE2 |
| NCT03082092 | COMPLETED | Osteoarthritis, Knee |
Queen Elizabeth Hospital, Hong Kong |
2017-06-01 | PHASE4 |
| NCT05531994 | COMPLETED | Healthy Volunteers |
Qilu Pharmaceutical Co., Ltd. |
2018-11-27 | |
| NCT03801226 | COMPLETED | Potential Applications for Heart Failure; Volume Overload |
Yale University |
2018-12-01 | EARLY_PHASE1 |
| NCT02404870 | COMPLETED | Healthy Volunteers |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2014-09-16 | PHASE1 |
| NCT03682952 | UNKNOWN | Chronic Renal Disease |
The Affiliated Hospital of Xuzhou Medical University |
2018-02-01 | PHASE4 |
| NCT03719261 | UNKNOWN | Postoperative Pain |
Cairo University |
2018-11 | PHASE2; PHASE3 |
| NCT03683563 | UNKNOWN | End-Stage Kidney Disease; Renal Dialysis; Central Venous Catheter; Biofilms |
University Medical Centre Ljubljana |
2018-04-11 | |
| NCT04471922 | COMPLETED | Healthy Volunteers |
Sihuan Pharmaceutical Holdings Group Ltd. |
2019-03-21 | PHASE1 |
| NCT03566979 | COMPLETED | Post-operative Dental Pain |
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division |
2018-08-13 | PHASE3 |
| NCT01894594 | TERMINATED | Sickle Cell Anemia; Chronic Kidney Disease; Metabolic Acidosis |
University Hospitals Cleveland Medical Center |
2013-06 | PHASE1 |
| NCT02628886 | UNKNOWN | Pneumonia |
London School of Hygiene and Tropical Medicine |
2016-03-11 | PHASE3 |
| NCT03698474 | COMPLETED | Colonoscopy |
Tomas Bata Hospital, Czech Republic |
2018-10-25 | PHASE4 |
| NCT02251041 | COMPLETED | Reperfusion Injury |
Universitaire Ziekenhuizen KU Leuven |
2014-09 | PHASE2 |
| NCT03189433 | TERMINATED | Drug Toxicity Psychotropic Agents Psychostimulants |
Eagle Pharmaceuticals, Inc. |
2017-08-12 | PHASE2 |
| NCT03226457 | COMPLETED | Heart Failure; Type 2 Diabetes Mellitus |
University of Dundee |
2017-12-11 | PHASE4 |
| NCT07738198 | COMPLETED | Dental Hypersensitivity |
Colgate Palmolive |
2018-11-26 | PHASE3 |
| NCT03335124 | TERMINATED | Sepsis; Septic Shock; Critical Illness; Fluid Overload |
University Medical Centre Ljubljana |
2017-09-26 | PHASE4 |
| NCT02216266 | UNKNOWN | Suspected Delirium After Elective or Emergency Heart Surgery; CAM-ICU Diagnosed Delirium |
PD Dr. Bertram Scheller |
2014-04 | PHASE3 |
| NCT03028428 | UNKNOWN | Osteoarthritis; Stem Cells; MSC |
Affiliated Hospital of Jiangsu University |
2016-12 | PHASE2 |
| NCT02169063 | WITHDRAWN | Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate Cancer |
University of Washington |
2015-12 | |
| NCT02982590 | COMPLETED | Left Ventricular Thrombosis |
Universiti Sains Malaysia |
2016-11 | PHASE3 |
| NCT03458715 | UNKNOWN | Type2 Diabetes |
Mackay Memorial Hospital |
2017-09-21 | PHASE4 |
| NCT02082717 | TERMINATED | Hypokalemia |
Baptist Health South Florida |
2014-02-25 | PHASE4 |
| NCT03226327 | COMPLETED | Hypertension; Hypertension With Abnormal Renal Function |
Peking University |
2018-03-28 | |
| NCT03513575 | COMPLETED | Saliva Altered; Oral Hygiene; pH; Tooth Structure; Disorder |
Dr Meru S |
2018-05-01 | |
| NCT03186053 | UNKNOWN | Heart Valve Diseases |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2017-06-15 | |
| NCT03811678 | COMPLETED | Chronic Hepatitis c |
Sunshine Lake Pharma Co., Ltd. |
2018-01-11 | PHASE1 |
| NCT03191903 | COMPLETED | Knee Osteoarthritis |
Anika Therapeutics, Inc. |
2017-05-25 | PHASE3 |
| NCT02779283 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia |
OHSU Knight Cancer Institute |
2016-01-13 | PHASE1 |
| NCT00952380 | COMPLETED | Venous Thromboembolism |
Pfizer |
2009-08 | PHASE2 |
| NCT03127644 | COMPLETED | Hyperkalemia |
AstraZeneca |
2017-06-14 | PHASE2; PHASE3 |
| NCT03110198 | UNKNOWN | Ulcerative Colitis, Unspecified |
Xijing Hospital of Digestive Diseases |
2017-05 | PHASE4 |
| NCT01941576 | COMPLETED | Congenital Heart Defects; Tetralogy Of Fallot |
Shanghai Jiao Tong University School of Medicine |
2013-09-01 | |
| NCT02937636 | COMPLETED | Gingivitis |
GlaxoSmithKline |
2017-09-19 | |
| NCT06337604 | COMPLETED | Helicobacter Pylori Infection |
TenNor Therapeutics Inc. |
2017-10-10 | PHASE1 |
| NCT02476526 | COMPLETED | Chronic Kidney Disease; Pulmonary Embolism; Renal Artery Stenosis; Pulmonary Cancer |
VA Greater Los Angeles Healthcare System |
2008-09 | PHASE4 |
| NCT03502434 | COMPLETED | Tendinopathy |
Biosplice Therapeutics, Inc. |
2017-09-11 | PHASE1 |
| NCT02964572 | COMPLETED | Type2 Diabetes Mellitus |
Yonsei University |
2016-11 | |
| NCT02403856 | COMPLETED | Calcifying Tendinitis of Shoulder |
Nantes University Hospital |
2015-04-04 | PHASE4 |
| NCT01973335 | COMPLETED | Heart Failure |
Hasselt University |
2013-11 | PHASE4 |
| NCT02619747 | TERMINATED | Gastro-esophageal Reflux Disease (GERD) |
Reckitt Benckiser Healthcare (UK) Limited |
2014-04 | PHASE3 |
| NCT02924350 | COMPLETED | Dentin Sensitivity |
GlaxoSmithKline |
2016-11-07 | |
| NCT03520595 | COMPLETED | Crown Lengthening Procedure With Ostectomy |
Tatyasaheb Kore Dental College |
2016-12-01 | |
| NCT03028285 | COMPLETED | Peripheral Vascular Disease |
POLYSAN Scientific & Technological Pharmaceutical Company |
2016-07-15 | PHASE1 |
| NCT02542592 | COMPLETED | Osteoarthrosis |
Rigshospitalet, Denmark |
2015-09 | PHASE2; PHASE3 |
| NCT03360266 | COMPLETED | Child; Early Childhood Caries |
Indira Gandhi Institute of Dental Science |
2016-03-21 | |
| NCT03571815 | COMPLETED | Dental Caries in Children |
University of Peradeniya |
2015-01-02 | |
| NCT02769494 | WITHDRAWN | Crohn's Disease; Oral Ulcer |
Xijing Hospital of Digestive Diseases |
2016-03 | PHASE3 |
| NCT02421367 | COMPLETED | Dengue |
U.S. Army Medical Research and Development Command |
2015-08 | PHASE1; PHASE2 |
| NCT01416636 | COMPLETED | Non-operable Chronic Thromboembolic Pulmonary Hypertension |
SciPharm SàRL |
2009-03 | PHASE3 |
| NCT02068781 | COMPLETED | Abdominal Obesity; Metabolic Syndrome; Sodium-sensitivity; Insulin Resistance; Hypertension |
Maastricht University Medical Center |
2014-07 | |
| NCT02909764 | COMPLETED | Development |
Monell Chemical Senses Center |
2016-01 | |
| NCT00475098 | COMPLETED | Lung Cancer; Non Small Cell Lung Cancer |
Assistance Publique - Hôpitaux de Paris |
2007-06 | PHASE3 |
| NCT02778516 | COMPLETED | ESRD |
University of Pennsylvania |
2014-08 | |
| NCT03841396 | COMPLETED | Injection Site Reaction |
Aspen Global Incorporated |
2016-06-02 | PHASE4 |
| NCT02425813 | WITHDRAWN | Acute Graft Versus Host Disease; Intestinal Graft Versus Host Disease |
Wake Forest University Health Sciences |
2015-10 | PHASE2 |
| NCT02317601 | COMPLETED | Delirium - Postoperative; Stress, Physiological |
Hvidovre University Hospital |
2014-12 | PHASE4 |
| NCT01178359 | COMPLETED | Cardiac Arrest |
University of Washington |
2010-01 | PHASE1 |
| NCT02111122 | COMPLETED | Sleep-wake Disturbances in Motor-phase Parkinson's Disease |
Christian Baumann |
2014-04 | PHASE2 |
| NCT02654405 | WITHDRAWN | Schizophrenic Disorders; Cognitive Function |
Nathan Kline Institute for Psychiatric Research |
2016-04 | PHASE2; PHASE3 |
| NCT03057535 | COMPLETED | Pulmonary Ventilation |
McGill University |
2015-05 | EARLY_PHASE1 |
| NCT02623062 | COMPLETED | Gastro-esophageal Reflux Disease (GERD) |
Reckitt Benckiser Healthcare (UK) Limited |
2013-12 | PHASE3 |
| NCT01895049 | COMPLETED | Kidney Transplantation; Cytomegalovirus |
Helio Tedesco Silva Junior |
2013-08 | PHASE4 |
| NCT02752971 | COMPLETED | Postoperative Pain |
Hospital Central Dr. Luis Ortega |
2015-02 | PHASE3 |
| NCT02061540 | COMPLETED | Primary Sclerosing Cholangitis (PSC) |
Mirum Pharmaceuticals, Inc. |
2014-03 | PHASE2 |
| NCT00568633 | TERMINATED | Leukemia, Myeloid; Leukemia; Acute Myeloid Leukemia (AML) |
Stanford University |
2007-08 | PHASE3 |
| NCT02412852 | COMPLETED | Diabetes |
TheraVasc Inc. |
2015-04-28 | PHASE2 |
| NCT02615912 | COMPLETED | Dermatitis |
Kimberly-Clark Corporation |
2015-11 | |
| NCT02295852 | UNKNOWN | Hypertension; Body Weight |
Federico II University |
2014-12 | |
| NCT00584350 | UNKNOWN | Radiographic Contrast Agent Nephropathy; Renal Failure; Coronary Heart Disease |
Université de Sherbrooke |
2007-11 | PHASE4 |
| NCT01316796 | COMPLETED | Sickle Cell Anemia; Sickle Cell Disease; Chronic Hemolytic Disorders |
National Heart, Lung, and Blood Institute (NHLBI) |
2011-03-15 | PHASE1 |
| NCT01165307 | COMPLETED | Menorrhagia |
Abimbola Famuyide |
2009-08 | PHASE4 |
| NCT02267538 | COMPLETED | Delirium; C.Surgical Procedure; Cardiac; Postoperative Complications |
Peking University First Hospital |
2014-11 | PHASE4 |
| NCT02448082 | COMPLETED | Dandruff |
University of Johannesburg |
2014-10 | PHASE2 |
| NCT03766984 | COMPLETED | Pharmacokinetics |
Grünenthal GmbH |
2015-06-07 | PHASE1 |
| NCT01773096 | COMPLETED | Constipation |
Shriners Hospitals for Children |
2013-05 | PHASE4 |
| NCT02142985 | COMPLETED | Hemodynamic Instability |
University of Monastir |
2014-04 | PHASE2 |
| NCT02869100 | COMPLETED | Spondyloarthritis |
Central Hospital, Nancy, France |
2013-01 | |
| NCT02563847 | COMPLETED | Endocrine System Diseases |
University Hospital, Basel, Switzerland |
2014-05 | |
| NCT00720109 | COMPLETED | Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 |
National Cancer Institute (NCI) |
2008-07-14 | PHASE2; PHASE3 |
| NCT02371616 | COMPLETED | Dentine Sensitivity |
GlaxoSmithKline |
2014-09-29 | |
| NCT01914224 | UNKNOWN | Prehypertension; Hypertension |
DongGuk University |
2013-03 | |
| NCT01977781 | COMPLETED | Ocular GVHD |
Massachusetts Eye and Ear Infirmary |
2013-12 | PHASE1 |
| NCT01984008 | COMPLETED | Bowel Preparation Before Colonoscopy |
Universal Integrated Corp. |
2013-10-23 | PHASE3 |
| NCT01896882 | UNKNOWN | Hemodialysis Patients |
Hospital de Clinicas de Porto Alegre |
2012-03 | |
| NCT01950949 | COMPLETED | Respiration, Artificial |
Yi Liu |
2012-07 | |
| NCT01549587 | COMPLETED | Gingivitis; Pregnancy |
Procter and Gamble |
2012-02 | |
| NCT01231139 | COMPLETED | Traumatic Brain Injury |
Dr. M.K. Saxena |
2010-10 | PHASE2 |
| NCT00961155 | UNKNOWN | Asthma |
Medical University of Lodz |
2009-08 | PHASE2 |
| NCT01266772 | UNKNOWN | Bronchial Asthma |
Medical University of Lodz |
2011-01 | PHASE3 |
| NCT01889173 | COMPLETED | Healthy Adults |
Tonix Pharmaceuticals, Inc. |
2013-06 | PHASE1 |
| NCT02255812 | COMPLETED | Exploratory Behavior |
University Hospital, Basel, Switzerland |
2013-03 | |
| NCT00476190 | COMPLETED | Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute |
2007-04 | PHASE2 |
| NCT01442168 | TERMINATED | Malaria, Falciparum |
Modus Therapeutics AB |
2011-09 | PHASE1; PHASE2 |
| NCT01463865 | COMPLETED | Pain, Postoperative |
Hillerod Hospital, Denmark |
2011-11 | |
| NCT00986557 | UNKNOWN | Graft Versus Host Disease; Nonneoplastic Condition |
University Hospital Birmingham |
2009-09 | PHASE2 |
| NCT01544998 | COMPLETED | Congestive Heart Failure |
Mayo Clinic |
2012-02 | PHASE1; PHASE2 |
| NCT01658501 | COMPLETED | Type 2 Diabetes Mellitus |
PhaseBio Pharmaceuticals Inc. |
2012-07 | PHASE2 |
| NCT00965094 | COMPLETED | Chronic Renal Failure |
Novartis Pharmaceuticals |
2009-12 | PHASE4 |
| NCT01552954 | COMPLETED | Hypertension; Chronic Kidney Disease; Microalbuminuria |
Seoul National University Bundang Hospital |
2012-02 | PHASE4 |
| NCT01619280 | UNKNOWN | Acute Lung Injury; Acute Respiratory Distress Syndrome; Sodium Nitroprusside; Hypoxia; Respiratory Failure |
Mount Sinai Hospital, Canada |
2012-05 | PHASE1 |
| NCT01647685 | UNKNOWN | Atherosclerosis |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2012-05 | PHASE1; PHASE2 |
| NCT01523509 | COMPLETED | Dental Caries |
Creighton University |
2012-08 | PHASE1 |
| NCT01831817 | COMPLETED | Dentinal Hypersensitivity |
GlaxoSmithKline |
2013-01 | PHASE2 |
| NCT01454791 | COMPLETED | Multiple Sclerosis |
Brown, Theodore R., M.D., MPH |
2011-01 | PHASE4 |
| NCT01350934 | COMPLETED | Osteoporosis, Postmenopausal |
Organon and Co |
2011-06-19 | PHASE4 |
| NCT01005758 | UNKNOWN | Leukemia |
Ohio State University Comprehensive Cancer Center |
2009-01 | PHASE2 |
| NCT00590512 | COMPLETED | Healthy |
Brigham and Women's Hospital |
2005-03 | EARLY_PHASE1 |
| NCT01155791 | TERMINATED | Urologic Neoplasms; Prostate Cancer; Prostate Cancer Metastatic Disease |
Sandy Srinivas |
2010-04 | PHASE1 |
| NCT01353508 | COMPLETED | Hypertension |
Novartis Pharmaceuticals |
2011-03 | PHASE2 |
| NCT01189461 | COMPLETED | Anti- VGF Inhibitor; Diabetic Macular Edema; Diabetic Retinopathy |
Pfizer |
2011-01 | PHASE3 |
| NCT01156220 | WITHDRAWN | Healthy Male and Female Volunteers |
Universitätsklinikum Hamburg-Eppendorf |
2012-01 | PHASE4 |
| NCT01592851 | COMPLETED | Dentine Hypersensitivity |
GlaxoSmithKline |
2012-04 | PHASE3 |
| NCT01135589 | UNKNOWN | Neutropenia; Hematopoietic Stem Cell Transplantation; Invasive Fungal Disease |
Asan Medical Center |
2010-04 | PHASE4 |
| NCT01641237 | COMPLETED | Enamel Erosion |
GlaxoSmithKline |
2012-03 | PHASE3 |
| NCT01382225 | COMPLETED | Dry Eye Syndrome |
Alcon Research |
2011-07 | PHASE3 |
| NCT01433016 | TERMINATED | Chronic Liver Disease; Hepatocellular Carcinoma (HCC) |
Meridian Bioscience, Inc. |
2011-11 | PHASE2 |
| NCT00722839 | COMPLETED | Nonneoplastic Condition |
City of Hope Medical Center |
2006-12 | PHASE1 |
| NCT01474499 | COMPLETED | Constipation |
Ferring Pharmaceuticals |
2011-09 | PHASE3 |
| NCT01009502 | TERMINATED | Myelodysplastic Syndromes |
Northwestern University |
2009-07 | PHASE1 |
| NCT00921050 | COMPLETED | Subclinical Hypothyroidism |
Universidad Autonoma de Nuevo Leon |
2009-06 | PHASE2; PHASE3 |
| NCT00636831 | COMPLETED | Inguinal Hernia |
Nihon University |
2007-07 | PHASE3 |
| NCT00718159 | COMPLETED | Acute Myeloid Leukemia; Essential Thrombocythemia |
Eli Lilly and Company |
2008-08 | PHASE1 |
| NCT01088555 | COMPLETED | Kidney Stones |
VA New York Harbor Healthcare System |
2009-11 | |
| NCT01039103 | TERMINATED | Acute Exacerbation of Remitting Relapsing Multiple Sclerosis; Clinically Isolated Syndrome |
Lakefront Biotherapeutics NV |
2009-12 | PHASE2 |
| NCT01311167 | TERMINATED | Liver Cirrhosis |
Insel Gruppe AG, University Hospital Bern |
2011-02 | PHASE3 |
| NCT01389284 | COMPLETED | Pain, Postoperative |
Bayer |
2011-06 | PHASE3 |
| NCT01383486 | COMPLETED | Pain |
Bayer |
2011-07 | PHASE3 |
| NCT01387464 | COMPLETED | Cataract |
Sun Pharmaceutical Industries Limited |
2011-07 | PHASE2 |
| NCT00405548 | COMPLETED | Left Ventricular Diastolic Dysfunction |
Mayo Clinic |
2008-03 | PHASE1; PHASE2 |
| NCT01691469 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2011-01 | PHASE1 |
| NCT00902031 | COMPLETED | Constipation; Palliative Care |
University of Alberta |
2006-04 | |
| NCT00345618 | COMPLETED | Embolism; Thrombosis |
Sanofi |
2006-06 | PHASE3 |
| NCT00679588 | COMPLETED | Venous Thromboembolism |
Sanofi |
2008-04 | PHASE3 |
| NCT00639912 | COMPLETED | Contrast Induced Nephropathy |
Azienda USL Reggio Emilia - IRCCS |
2007-06 | PHASE4 |
| NCT00843024 | COMPLETED | Migraine Disorders |
GlaxoSmithKline |
2008-12 | PHASE3 |
| NCT00531765 | COMPLETED | Contrast Induced Nephropathy |
King Faisal Specialist Hospital & Research Center |
2007-06 | |
| NCT01094704 | COMPLETED | Cystic Fibrosis |
University of North Carolina, Chapel Hill |
2009-11 | PHASE1 |
| NCT00001328 | COMPLETED | Brain Neoplasm; Neoplasm Metastasis |
National Institute of Neurological Disorders and Stroke (NINDS) |
1992-08-21 | PHASE1 |
| NCT00914836 | WITHDRAWN | Tendonitis; Bursitis |
HaEmek Medical Center, Israel |
2009-06 | |
| NCT01088594 | COMPLETED | Type 2 Diabetes Mellitus |
Solvay Pharmaceuticals |
2010-02 | PHASE1 |
| NCT00781339 | COMPLETED | Asymptomatic Bacteriuria |
NovaBay Pharmaceuticals, Inc. |
2008-10 | PHASE2 |
| NCT00893737 | COMPLETED | Migraine |
Cady, Roger, M.D. |
2009-06 | PHASE4 |
| NCT01167946 | COMPLETED | Alopecia Totalis; Alopecia Universalis; Ophiasic Alopecia |
King Saud University |
2003-01 | PHASE4 |
| NCT00574197 | COMPLETED | Gastrointestinal Symptoms; Heart Transplantation |
Cedars-Sinai Medical Center |
2006-06 | PHASE4 |
| NCT01858090 | COMPLETED | Elective Caesarean Section Surgeries |
Baskent University |
2009-01 | PHASE3 |
| NCT00057811 | COMPLETED | Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Untreated Childhood Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2004-06 | PHASE2 |
| NCT00627731 | COMPLETED | Asthma |
Hamamatsu University |
2007-06 | PHASE4 |
| NCT00097448 | COMPLETED | Sudden Deafness |
Massachusetts Eye and Ear Infirmary |
2004-12 | PHASE3 |
| NCT00479687 | COMPLETED | Osteoarthritis of the Shoulder |
Bioventus LLC |
2007-05 | |
| NCT00658775 | COMPLETED | Gastroesophageal Reflux Disease (GERD) |
Eisai Inc. |
2008-02 | PHASE3 |
| NCT00787150 | COMPLETED | Atrial Fibrillation |
Pfizer |
2008-06 | PHASE2 |
| NCT00488514 | COMPLETED | Migraine Disorders |
GlaxoSmithKline |
2007-07-13 | PHASE3 |
| NCT00453336 | COMPLETED | Head and Neck Cancer; Precancerous/Nonmalignant Condition |
University of Miami |
2003-06 | PHASE2 |
| NCT00573170 | COMPLETED | Migraine Disorders; Migraine, Acute |
GlaxoSmithKline |
2008-02 | PHASE3 |
| NCT00251004 | COMPLETED | Kidney Transplantation; Graft Rejection |
Novartis |
2005-10 | PHASE3 |
| NCT03362216 | COMPLETED | Soft Tissue Injuries |
Peking University People's Hospital |
2009-04-07 | |
| NCT00969449 | COMPLETED | Pharmacokinetics |
Bayer |
2009-04 | PHASE1 |
| NCT01442727 | COMPLETED | Arsenical Melanosis; Arsenical Keratosis; Arsenical Cancers; Arsenicosis; Arsenic Exposure; Arsenic Toxicity; Arsenic Poisoning |
Texas Tech University |
2006-12 | PHASE3 |
| NCT00805090 | COMPLETED | Renal Insufficiency, Chronic; Hepatic Insufficiency; Healthy |
Javelin Pharmaceuticals |
2008-12 | PHASE1 |
| NCT00245856 | COMPLETED | Deep-Vein Thrombosis |
University of Oklahoma |
2002-09 | PHASE4 |
| NCT00188604 | COMPLETED | Breast Neoplasms; Lymphedema |
University Health Network, Toronto |
2004-01 | PHASE2 |
| NCT00618709 | COMPLETED | Healthy |
Kythera Biopharmaceuticals |
2008-01 | PHASE1 |
| NCT00237783 | TERMINATED | Hemodialysis; Hypotension |
Yale University |
2005-10 | PHASE1 |
| NCT00598078 | COMPLETED | Essential Tremor |
Jazz Pharmaceuticals |
2007-12 | PHASE2 |
| NCT00142493 | COMPLETED | Memory Losses; Amnesia-Memory Loss |
Memorial Sloan Kettering Cancer Center |
2004-09 | PHASE1 |
| NCT00875784 | COMPLETED | Migraine Disorders |
GlaxoSmithKline |
2008-05-06 | PHASE1 |
| NCT00693355 | COMPLETED | Healthy |
Maastricht University Medical Center |
2005-12 | |
| NCT00868296 | COMPLETED | Gastroesophageal Reflux |
Wyeth is now a wholly owned subsidiary of Pfizer |
2006-03 | PHASE3 |
| NCT00751556 | COMPLETED | Healthy |
Bayer |
2008-02 | PHASE1 |
| NCT00117338 | COMPLETED | Asthma |
Organon and Co |
2005-07 | PHASE3 |
| NCT01118273 | COMPLETED | Sleep |
Bayer |
2008-01 | PHASE4 |
| NCT00387881 | COMPLETED | Migraine, Without Aura |
GlaxoSmithKline |
2006-09 | PHASE3 |
| NCT01931514 | COMPLETED | Healthy |
Torrent Pharmaceuticals Limited |
PHASE1 | |
| NCT00410215 | COMPLETED | Colonoscopy |
Queen's University |
2006-02 | PHASE4 |
| NCT00256100 | TERMINATED | Renal Failure |
Melbourne Health |
2004-06 | |
| NCT00382993 | COMPLETED | Migraine Disorders |
GlaxoSmithKline |
2006-12 | PHASE3 |
| NCT00383162 | COMPLETED | Migraine Disorders |
GlaxoSmithKline |
2006-11 | PHASE3 |
| NCT00662012 | COMPLETED | Leishmaniasis |
U.S. Army Medical Research and Development Command |
2002-06 | PHASE2 |
| NCT00755794 | COMPLETED | Asthma |
Organon and Co |
2006-06 | PHASE3 |
| NCT00228046 | COMPLETED | Attention Deficit Disorder With Hyperactivity; Conduct Disorder; Oppositional Defiant Disorder |
Stony Brook University |
2004-01 | PHASE4 |
| NCT00543205 | TERMINATED | Advanced Melanoma and Normal or Impaired; Hepatic Function |
Genta Incorporated |
2005-08 | PHASE2; PHASE3 |
| NCT00258375 | COMPLETED | Breast Cancer |
NCIC Clinical Trials Group |
2005-10-21 | PHASE2 |
| NCT00385008 | COMPLETED | Migraine Disorders |
GlaxoSmithKline |
2006-09-13 | PHASE3 |
| NCT00329459 | COMPLETED | Migraine Disorders |
GlaxoSmithKline |
2006-05 | PHASE3 |
| NCT00329355 | COMPLETED | Migraine; Migraine Disorders |
GlaxoSmithKline |
2006-05 | PHASE3 |
| NCT00974441 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2006-08 | PHASE1 |
| NCT00086944 | COMPLETED | Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma |
National Cancer Institute (NCI) |
2004-05 | PHASE1; PHASE2 |
| NCT00240630 | COMPLETED | Migraine Disorders; Migraine |
GlaxoSmithKline |
2005-10 | PHASE3 |
| NCT00240617 | COMPLETED | Migraine Disorders |
GlaxoSmithKline |
2005-10 | PHASE3 |
| NCT00445107 | COMPLETED | Asthma |
Organon and Co |
2005-11-01 | PHASE3 |
| NCT00398151 | COMPLETED | Asthma |
Organon and Co |
2005-08-01 | PHASE3 |
| NCT00398099 | COMPLETED | Infection; Pneumonia; Urinary Tract Infection |
Merck Sharp & Dohme LLC |
2005-07 | PHASE3 |
| NCT00647621 | COMPLETED | Healthy |
Mylan Pharmaceuticals Inc |
2005-10 | PHASE1 |
| NCT01179659 | COMPLETED | Healthy |
Kremers Urban Development Company |
2005-09 | PHASE1 |
| NCT00147004 | COMPLETED | Shock, Septic |
Hadassah Medical Organization |
2002-03 | PHASE3 |
| NCT00039481 | COMPLETED | Cardiac Toxicity; Unspecified Childhood Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2002-11 | PHASE1 |
| NCT00913848 | COMPLETED | Epilepsy; Bipolar Disorder |
Sandoz |
2005-10 | PHASE1 |
| NCT00494533 | TERMINATED | Pulmonary Arterial Hypertension |
United Therapeutics |
2005-03 | PHASE4 |
| NCT00042978 | COMPLETED | Extensive Stage Small Cell Lung Cancer; Recurrent Small Cell Lung Cancer |
National Cancer Institute (NCI) |
2003-04 | PHASE2 |
| NCT00238966 | COMPLETED | Renal Transplantation |
Novartis |
2002-11 | PHASE4 |
| NCT00077818 | COMPLETED | Acute Coronary Syndrome |
Sanofi |
2002-06 | PHASE4 |
| NCT00241059 | COMPLETED | Renal Transplantation |
Novartis |
2002-08 | PHASE4 |
| NCT00054249 | COMPLETED | Gastric Cancer |
University Hospitals Seidman Cancer Center |
2002-09 | PHASE2 |
| NCT00224055 | COMPLETED | Anemia, Iron-Deficiency; Kidney Failure, Chronic |
Watson Pharmaceuticals |
2003-04 | PHASE4 |
| NCT00646711 | COMPLETED | Pediatric Epilepsy |
Abbott |
2003-02 | PHASE2 |
| NCT00005810 | COMPLETED | Prostate Cancer |
Alliance for Clinical Trials in Oncology |
2000-03 | PHASE2 |
| NCT00228657 | COMPLETED | Pressure Ulcer, Area; Pressure Ulcer, Grade; Albumin Level; Risk Score; Length of ICU Stay |
Bayside Health |
2002-07 | PHASE1; PHASE2 |
| NCT01146093 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2002-11 | PHASE1 |
| NCT00003359 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Memorial Sloan Kettering Cancer Center |
1998-04 | PHASE1 |
| NCT00000970 | COMPLETED | Cytomegalovirus Retinitis; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00345150 | COMPLETED | Hypertension |
Regional Hospital Holstebro |
PHASE1 | |
| NCT00102271 | COMPLETED | Healthy |
National Heart, Lung, and Blood Institute (NHLBI) |
2005-01-19 | PHASE1 |
| NCT00290602 | COMPLETED | Acute Respiratory Distress Syndrome; Acute Lung Injury; Postoperative Complications |
National Cancer Center, Korea |
2004-02 | PHASE2 |
| NCT00483795 | COMPLETED | Corneal Staining |
Innovative Medical |
PHASE4 | |
| NCT00068068 | COMPLETED | Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis |
Light Sciences LLC |
2003-10 | PHASE2 |
| NCT00392405 | UNKNOWN | Contrast Induced Nephropathy |
Norton Community Hospital |
2006-11 | PHASE2 |
| NCT00017602 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Genta Incorporated |
2000-12 | PHASE3 |
| NCT00000528 | COMPLETED | Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases |
National Heart, Lung, and Blood Institute (NHLBI) |
1986-09 | PHASE3 |
| NCT00000522 | COMPLETED | Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases |
University of Minnesota |
1985-08 | PHASE2 |
| NCT00137293 | TERMINATED | Arrhythmia |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-11 | PHASE2 |
| NCT00006240 | COMPLETED | Leukemia |
National Heart, Lung, and Blood Institute (NHLBI) |
2000-10 | PHASE2 |
| NCT00195312 | TERMINATED | HIV Infections |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-08 | PHASE1 |
| NCT00353964 | UNKNOWN | Ocular Inflammation |
Evolutec Group |
PHASE2 | |
| NCT00636064 | COMPLETED | Pain |
Pfizer |
2003-01 | PHASE3 |
(data from https://clinicaltrials.gov, updated on 2026-08-31)
Check the
Sodium succinate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Compliance for Clinical Use
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Jump to
Note: Technical data last updated: Sep 1, 2026.